Page last updated: 2024-08-17

thymidine and decitabine

thymidine has been researched along with decitabine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19908 (80.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pískala, A; Veselý, J1
Moriconi, WJ; Slavik, M; Taylor, S1
Chabot, GG; Momparler, RL1
Bartolucci, S; Bouchard, J; Momparler, LF; Momparler, RL; Nucci, R; Raia, CA; Rossi, M; Sepe, S; Vaccaro, C1
Covey, JM; Zaharko, DS1
Cadman, E; Grant, S; Margolin, J; Rauscher, F1
Ellims, PH1
Bouchard, J; Chabot, GG; Momparler, RL1
Bruserud, Ø; Ryningen, A; Stapnes, C1
Cai, JP; Feng, J; He, Q; Li, L; Liu, X; McNutt, MA; Sekiguchi, M; Tu, B; Wang, H; Wu, L; Yang, Y; Yu, Y; Zhao, Y; Zhu, WG1

Reviews

1 review(s) available for thymidine and decitabine

ArticleYear
Thymidine as an anticancer agent, alone or in combination. A biochemical appraisal.
    Cancer chemotherapy and pharmacology, 1982, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Agents; Azacitidine; Cytarabine; Decitabine; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Neoplasms; Thymidine

1982

Other Studies

9 other study(ies) available for thymidine and decitabine

ArticleYear
Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    Neoplasma, 1986, Volume: 33, Issue:1

    Topics: Animals; Antineoplastic Agents; Azacitidine; Bone Marrow; Bone Marrow Cells; Cell Division; Cell Line; Cell Survival; Cytarabine; Decitabine; Drug Evaluation, Preclinical; Kinetics; Leukemia L1210; Leukocyte Count; Male; Mice; Mice, Inbred DBA; Nucleosides; Phosphorylation; Thymidine

1986
3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
    Investigational new drugs, 1986, Volume: 4, Issue:1

    Topics: 3-Deazauridine; Acute Disease; Animals; Antineoplastic Agents; Azacitidine; Cytarabine; Decitabine; Drug Evaluation; Drug Synergism; Galactosamine; Humans; Kinetics; Leukemia; Neoplasms; Thymidine; Uridine

1986
Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
    Leukemia research, 1986, Volume: 10, Issue:5

    Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Cycle; Cell Survival; Cells, Cultured; Decitabine; DNA, Neoplasm; Leukemia L1210; Mice; Thymidine

1986
5-AZA-2'-deoxycytidine synergistic action with thymidine on leukemic cells and interaction of 5-AZA-dCMP with dCMP deaminase.
    Advances in experimental medicine and biology, 1986, Volume: 195 Pt B

    Topics: Animals; Azacitidine; Cell Line; Cell Survival; DCMP Deaminase; Decitabine; Deoxycytosine Nucleotides; DNA, Neoplasm; Drug Synergism; Humans; Methylation; Mice; Nucleotide Deaminases; Thymidine; Thymine Nucleotides

1986
Effects of 5-aza-2'-deoxycytidine in combination with the biochemical modulator thymidine or the immune modulator pyran copolymer on L1210 leukemia-bearing mice.
    Cancer treatment reports, 1984, Volume: 68, Issue:10

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Body Weight; Decitabine; Leukemia L1210; Male; Mice; Polymers; Pyran Copolymer; Thymidine; Time Factors

1984
Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
    Cancer research, 1982, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents; Azacitidine; Biological Transport; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Decitabine; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Humans; Leukemia L1210; Leukemia, Myeloid, Acute; Mice; Thymidine; Time Factors

1982
Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
    Biochemical pharmacology, 1983, Apr-01, Volume: 32, Issue:7

    Topics: 3-Deazauridine; Adult; Arabinofuranosyluracil; Azacitidine; Cytarabine; Cytidine Deaminase; Cytosine; Decitabine; Humans; Kinetics; Liver; Nucleoside Deaminases; Substrate Specificity; Thymidine

1983
Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting.
    Leukemia research, 2007, Volume: 31, Issue:9

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Azacitidine; Cell Cycle; Cell Differentiation; Cell Proliferation; Decitabine; DNA, Mitochondrial; Enzyme Inhibitors; Epigenesis, Genetic; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Phenylbutyrates; Thymidine; Tumor Cells, Cultured; Tumor Stem Cell Assay

2007
Proliferating cell nuclear antigen is protected from degradation by forming a complex with MutT Homolog2.
    The Journal of biological chemistry, 2009, Jul-17, Volume: 284, Issue:29

    Topics: Acetylation; Azacitidine; Blotting, Western; Cell Cycle; Cell Line; Cell Line, Tumor; Decitabine; Deoxyguanine Nucleotides; Fluorescence Resonance Energy Transfer; Humans; Hydrogen Peroxide; Immunoprecipitation; Luminescent Proteins; Microscopy, Confocal; Oxidants; Phosphoric Diester Hydrolases; Proliferating Cell Nuclear Antigen; Protein Binding; Pyrophosphatases; Recombinant Fusion Proteins; RNA Interference; Thymidine; Transfection; Ultraviolet Rays

2009